New nasal method for COPD meds shows promise in small trial
NCT ID NCT02812979
First seen Jan 06, 2026 · Last updated Jun 02, 2026 · Updated 19 times
Summary
This study tested if a high-flow nasal system (AIRVO 2) can deliver the bronchodilator salbutamol as effectively as a standard mask for people with COPD. 25 adults with COPD and reversible airway blockage took part. The goal was to see if the new method works just as well at improving lung function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Service de Réanimation Polyvalente
Tours, 37044, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.